Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 299

Results For "RI"

11112 News Found

Velocity Clinical Research invests in Indian tech, acquires TrierHealth
Biotech | February 22, 2022

Velocity Clinical Research invests in Indian tech, acquires TrierHealth

The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials


Solvay invests in Zurich-based 3D printing startup
Startup | February 22, 2022

Solvay invests in Zurich-based 3D printing startup

9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare


Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines
News | February 22, 2022

Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines

Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply


IFF to acquire contract manufacturer of dietary supplements Health Wright Products
News | February 22, 2022

IFF to acquire contract manufacturer of dietary supplements Health Wright Products

The sale is expected to close in the first quarter of 2022


Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s
Biotech | February 21, 2022

Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s

Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company


Strides receives USFDA approval for Amantadine Hydrochloride capsules
Drug Approval | February 21, 2022

Strides receives USFDA approval for Amantadine Hydrochloride capsules

To be marketed by Strides Pharma Inc. in the US market


WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients
Drug Approval | February 20, 2022

WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients

Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra


Hinduja Global Solutions bags contract from the UK Health Security Agency to provide critical services
News | February 20, 2022

Hinduja Global Solutions bags contract from the UK Health Security Agency to provide critical services

The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.


cbdMD becomes first American CBD brand to receive UK validation
Biotech | February 19, 2022

cbdMD becomes first American CBD brand to receive UK validation

The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK


Interactive App from rXperius to provide pharma industry with patient insights
Digitisation | February 18, 2022

Interactive App from rXperius to provide pharma industry with patient insights

The insights collected by the app will support the pharmaceutical industry’s efforts to further improve patients’ lives by providing actionable data on patients’ individual experiences